Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 47

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 47
---
 broad array of investments and actively trade debt and equity securities (or related derivative
securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments
and securities activities may involve securities and/or instruments of ours and/or persons and entities with relationships with us. The
underwriters and their affiliates may also make investment recommendations and/or publish or express independent research views in respect
of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such
securities and instruments.

Electronic Distribution

In connection with the offering, certain of the
underwriters or securities dealers may distribute prospectuses by electronic means such as email.

<div align='center'>S-27</div>

Selling Restrictions

Notice to Prospective Investors in Canada

The shares of Series B Preferred Stock may
be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National
Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined
in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares Series B
Preferred Stock must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of
applicable securities laws.

Securities legislation in certain provinces or
territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto)
contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit
prescribed by the securities legislation of the purchaser’s province or territory. The purchaser should refer to any applicable
provisions of the securities legislation of the purchaser’s province or territory for particulars of these rights or consult with
a legal advisor.

Pursuant to section 3A.3 of National Instrument
33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding
underwriter conflicts of interest in connection with this offering.

Prohibition of Sales to European Economic Area Retail Investors

The shares of Series B Preferred Stock are
not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail
invest